ROBERT COOK: Open Payments
NPI 1568407690 · PLANO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,283 in 72 payments from 23 companies in 2025. Trend: 2023 $1,511 · 2024 $1,212 · 2025 $1,283
Food & beverage: $1,283
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $200 |
| PFIZER INC. | 11 | $183 |
| GlaxoSmithKline, LLC. | 5 | $108 |
| Amgen Inc. | 5 | $89 |
| Otsuka America Pharmaceutical, Inc. | 4 | $82 |
| Axsome Therapeutics, Inc. | 3 | $76 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $60 |
| Currax Pharmaceuticals LLC | 4 | $58 |
| Exact Sciences Corporation | 3 | $53 |
| Lilly USA, LLC | 3 | $50 |
Products named: ELIQUIS, REXULTI, VRAYLAR, UBRELVY, NURTEC ODT, CAPLYTA, CONTRAVE, TRELEGY ELLIPTA.
Industry payments across TX — which companies pay providers there.
